Seroepidemiology of chronic fatigue syndrome: a case-control study.
Mawle, A C, Nisenbaum, R, Dobbins, J G et al. · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 1995 · DOI
Quick Summary
Researchers tested people with ME/CFS and healthy control groups for antibodies to many common viruses, including herpesviruses and enteroviruses. They found no differences between the two groups—patients with ME/CFS did not have higher levels of antibodies to any of the viruses tested. This suggests that recent or past infection with these particular viruses is not a distinguishing feature of ME/CFS.
Why It Matters
This study directly addresses a common hypothesis that ME/CFS may be triggered or perpetuated by specific viral infections. Understanding what is NOT associated with ME/CFS helps researchers refocus efforts on other potential mechanisms and prevents resources from being spent pursuing false leads.
Observed Findings
No infectious agent was significantly associated with CFS diagnosis in the study population.
No elevated antibody titers to any herpesvirus were found in ME/CFS patients compared to controls.
No serological evidence of enteroviral exposure distinguished ME/CFS patients from matched controls.
The study examined a wide range of infectious agents without identifying any pattern differentiation.
Inferred Conclusions
Common infectious agents tested are not uniformly associated with ME/CFS development in this population.
Elevated serology to major herpesviruses and enteroviruses does not characterize this ME/CFS patient cohort.
Simple, uniform infectious triggers for CFS may not explain disease etiology in these patients.
Remaining Questions
Are there geographic or demographic variations in infectious agent associations with ME/CFS that this single-site study could not detect?
Could ME/CFS be triggered by viruses not included in this serological panel, or by non-infectious mechanisms entirely?
Does latent or reactivated viral infection (detectable by methods other than serology) play a role in ME/CFS pathogenesis?
What This Study Does Not Prove
Negative antibody testing does not prove that viruses play no role in ME/CFS—it only shows these particular viruses are not uniformly elevated in this patient group. The study cannot exclude the possibility of latent viral reactivation without high antibody titers, prior infections that resolved completely, or viruses not included in the testing panel. Additionally, findings from Atlanta may not apply to ME/CFS patients in other geographic regions.